A roundup of the latest news and updates for patients with metastatic breast cancer from CURE®.
There have been several updates in the field of metastatic breast cancer over the last several weeks.
Here, CURE® looks back at some of the latest news and updates affecting patients with metastatic breast cancer.
FDA to Review Inavolisib Combo for HR-Positive, HER2-Negative Breast Cancer
May 22nd 2024The Food and Drug Administration granted a breakthrough therapy designation to inavolisib plus Ibrance and fulvestrant for HR-positive, HER2-negative locally advanced or metastatic breast cancer.
Read More
Mother with Stage 4 Breast Cancer and Her Family 'Focus on the Living'
July 27th 2023Christina McAmis’ cancer journey began when she found a lump while breastfeeding. The attorney and mother of three tells the “Cancer Horizons” podcast what the last nine years have been like for her and her family.
Listen